Cardiovascular risk factors and diseases precede oral hypoglycaemic therapy in patients with type 2 diabetes mellitus☆
To access this article, please choose from the options below
☆ This study was supported by an unrestricted NovoNordisk Fellowship.
PII: S0895-4356(01)00482-6
© 2002 Elsevier Science Inc. All rights reserved.
